Author: Villanueva A. Durantini1 E.N. Stockert J.C. Rello S. Vidania2 R. Cañete M. Juarranz A. Arranz R. Rivarola3 V.
Publisher: Cognizant Communication Corporation
ISSN: 1460-2148
Source: Anti-Cancer Drug Design, Vol.16, Iss.6, 2001-12, pp. : 279-290
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The isocoumarin derivative NM-3 enhances in vivo tumour response to radiotherapy
Inpharma, Vol. 1, Iss. 1276, 2001-01 ,pp. :
By Ishibashi T. Yoshida Y. Imai S. Nishio M.
General Pharmacology, Vol. 32, Iss. 1, 1999-01 ,pp. :
Potent tumour immunotherapy with stem cells
Inpharma, Vol. 1, Iss. 1399, 2003-01 ,pp. :